RT Journal Article
SR Electronic
T1 Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e007047
DO 10.1136/jitc-2023-007047
VO 11
IS 10
A1 Zhou, Caicun
A1 Srivastava, Minu K
A1 Xu, Hao
A1 Felip, Enriqueta
A1 Wakelee, Heather
A1 Altorki, Nasser
A1 Reck, Martin
A1 Liersch, Rüdiger
A1 Kryzhanivska, Anna
A1 Oizumi, Satoshi
A1 Tanaka, Hiroshi
A1 Hamm, John
A1 McCune, Steven L
A1 Bennett, Elizabeth
A1 Gitlitz, Barbara
A1 McNally, Virginia
A1 Ballinger, Marcus
A1 McCleland, Mark
A1 Zou, Wei
A1 Das Thakur, Meghna
A1 Novello, Silvia
YR 2023
UL http://jitc.bmj.com/content/11/10/e007047.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.